Literature DB >> 22936826

Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction.

Shannon M Dunlay1, Véronique L Roger, Susan A Weston, Ruoxiang Jiang, Margaret M Redfield.   

Abstract

BACKGROUND: Heart failure (HF) can occur in patients with preserved (HFpEF, EF≥50%) or reduced (HFrEF, EF<50%) ejection fraction (EF), but changes in EF after HF diagnosis are not well described. METHODS AND
RESULTS: Among a community cohort of incident HF patients diagnosed from 1984 to 2009 in Olmsted County, Minnesota, we obtained all EFs assessed by echocardiography from initial HF diagnosis until death or last follow-up through March 2010. Mixed effects models fit a unique linear regression line for each person using serial EF data. Compiled results allowed estimates of the change in EF over time in HFpEF and HFrEF. Among 1233 HF patients (48.3% male, mean age 75.0 years, mean follow-up 5.1 years), 559 (45.3%) had HFpEF at diagnosis. In HFpEF, on average, EF decreased by 5.8% over 5 years (P<0.001) with greater declines in older individuals and those with coronary disease. Conversely, EF increased in HFrEF (average increase 6.9% over 5 years, P<0.001). Greater increases were noted in women, younger patients, individuals without coronary disease, and those treated with evidence-based medications. Overall, 39% of HFpEF patients had an EF<50% and 39% of HFrEF patients had an EF≥50% at some point after diagnosis. Decreases in EF over time were associated with reduced survival whereas increases in EF were associated with improved survival.
CONCLUSIONS: These data suggest that progressive contractile dysfunction may contribute to the pathophysiology of HFpEF. Prospective longitudinal studies are needed to confirm these observations and establish the mechanism and clinical relevance of decline in EF over time in HFpEF.

Entities:  

Mesh:

Year:  2012        PMID: 22936826      PMCID: PMC3661289          DOI: 10.1161/CIRCHEARTFAILURE.111.966366

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  39 in total

1.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

4.  A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.

Authors:  M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

5.  Marked spontaneous improvement in ejection fraction in patients with congestive heart failure.

Authors:  G S Francis; T H Johnson; S Ziesche; M Berg; P Boosalis; J N Cohn
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

6.  Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study.

Authors:  Mark H Drazner; J Eduardo Rame; Emily K Marino; John S Gottdiener; Dalane W Kitzman; Julius M Gardin; Teri A Manolio; Daniel L Dries; David S Siscovick
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

7.  Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.

Authors:  M R Bristow; F L Anderson; J D Port; L Skerl; R E Hershberger; P Larrabee; J B O'Connell; D G Renlund; K Volkman; J Murray
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

8.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

Review 9.  The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure.

Authors:  M O Boluyt; O H Bing; E G Lakatta
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

10.  Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction.

Authors:  A F Amico; G S Lichtenberg; S A Reisner; C K Stone; R G Schwartz; R S Meltzer
Journal:  Am Heart J       Date:  1989-12       Impact factor: 4.749

View more
  89 in total

1.  Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

Review 2.  Epidemiology of "Heart Failure with Recovered Ejection Fraction": What do we do After Recovery?

Authors:  Johny S Kuttab; Michael S Kiernan; Amanda R Vest
Journal:  Curr Heart Fail Rep       Date:  2015-12

3.  Atherosclerotic Burden and Heart Failure After Myocardial Infarction.

Authors:  Yariv Gerber; Susan A Weston; Maurice Enriquez-Sarano; Sheila M Manemann; Alanna M Chamberlain; Ruoxiang Jiang; Véronique L Roger
Journal:  JAMA Cardiol       Date:  2016-05-01       Impact factor: 14.676

4.  Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study.

Authors:  Yariv Gerber; Susan A Weston; Cecilia Berardi; Sheila M McNallan; Ruoxiang Jiang; Margaret M Redfield; Véronique L Roger
Journal:  Am J Epidemiol       Date:  2013-08-29       Impact factor: 4.897

5.  Heart failure with recovered ejection fraction.

Authors:  Kazuaki Tanabe; Takahiro Sakamoto
Journal:  J Echocardiogr       Date:  2018-09-14

Review 6.  The pathophysiology of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

7.  Arterial stiffness is associated with increase in blood pressure over time in treated hypertensives.

Authors:  Thais Coutinho; Kent R Bailey; Stephen T Turner; Iftikhar J Kullo
Journal:  J Am Soc Hypertens       Date:  2014-04-04

8.  Natural history of left ventricular ejection fraction in patients with heart failure.

Authors:  Christina L Clarke; Gary K Grunwald; Larry A Allen; Anna E Barón; Pamela N Peterson; David W Brand; David J Magid; Frederick A Masoudi
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-10-15

Review 9.  Current Management and Future Directions of Heart Failure With Preserved Ejection Fraction: a Contemporary Review.

Authors:  Chayakrit Krittanawong; Marrick L Kukin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

10.  Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings.

Authors:  Andrew H Coles; Kimberly Fisher; Chad Darling; Jorge Yarzebski; David D McManus; Joel M Gore; Darleen Lessard; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2014-07-02       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.